title: Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndrome.
abstract: As new therapies and new applications of existing drugs expand, pediatricians are often in the position of trying to decide when and whether use of a new treatment is appropriate. In this paper, we address this dilemma by focusing on ethical issues in the use of growth hormone therapy for children with Down syndrome and Prader-Willi syndrome as an example. We discuss six major questions that link scientific and ethical considerations in analyzing these difficult issues.
authors.affiliation: Rainbow Babies and Childrens Hospital, Cleveland, OH, USA.
authors.forename: E
authors.initials: E
authors.lastname: Kodish
authors.forename: L
authors.initials: L
authors.lastname: Cuttler
mesh_terms: D002648:Child; D004314:Down Syndrome / Q000628:therapy*; D004992:Ethics, Medical; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D011218:Prader-Willi Syndrome / Q000628:therapy*
chemical_list: D019382:Human Growth Hormone